Research Y-ibritumomab tiuxetan and high-dose BEAM chemotherapy conditioning followed by autologous stem cell transplantation shows encouraging response and survival rates in refractory diffuse large B-cell lymphoma patients
Research Rituximab helps overcome adverse effects of diabetes mellitus for patients with diffuse large B-cell lymphoma.
